Christine Winoto

Christine Winoto is Deputy Director of QB3, Director of the Rosenman Institute at UCSF, and Founder
and Venture Partner at MedTech Venture Partners I, LLP. Christine also manages the QB3 Life Science
Pitch Summits, corporate partnership, and QB3 operations. Before joining QB3, she managed business
strategy and capital planning for Kaiser Permanente both on the hospital and health plan sides, and
managed business development at Genencor. In addition to consulting for startups and venture capital,
she has also held R&D and operations positions in medical device companies including Physiometrix
(IPO, then acquired by Hospira), Cardiovasc and Heartport. Christine also worked in mergers and
acquisitions at the London office of the Dutch investment bank ABN AMRO. Christine holds an MBA
from Erasmus University in the Netherlands.